← Back
$CORT All transactions

CORCEPT THERAPEUTICS INC

M 10b5-1 Plan

$ Value

$0

Shares

32,262

Price

$0

Filed

May 20

Insider

Name

Guyer William

Title

Chief Development Officer

CIK

0001879013

Roles

Officer

Transaction Details

Transaction Date

2025-05-16

Code

M

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

410,000

Footnotes

The transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on November 27, 2024 in effect at the time of this transaction. | Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $73.94 to $74.66 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. | Fully exercisable.

Filing Info

Accession No.

0000950170-25-075484

Form Type

4

Issuer CIK

0001088856

Guyer William's History

Date Ticker Type Value
2026-04-07 CORT M $433K
2026-04-07 CORT $819K
2026-04-07 CORT M $0
2026-03-20 CORT M $255K
2026-03-20 CORT $424K
2026-03-20 CORT M $0
2026-02-03 CORT M $433K
2026-02-03 CORT $817K
2026-02-03 CORT M $0
2026-01-06 CORT M $433K

Other Insiders at CORT (90d)

Insider Bought Sold Last
BAKER G LEONARD JR 2026-01-27
WILSON JAMES N 2026-04-06
BELANOFF JOSEPH K
Chief Executive Officer
$1.3M 2026-03-25
Hunt Hazel
Chief Scientific Officer
2026-02-09
Guyer William
Chief Development Officer
$2.1M 2026-04-07